Argus
•
Aug 30, 2023
QURE: What does Argus have to say about QURE?
Summary
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases.
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Alnylam Pharmaceuticals, Inc.
Oct 30, 2026
•
ALNY
Analyst Report: Biogen Inc.
Oct 29, 2026
•
BIIB
Analyst Report: Baxter International Inc.
Oct 29, 2026
•
BAX
Analyst Report: Biogen Inc
Oct 29, 2026
•
BIIB
Market Digest: BIIB, CMCSA, CNC, IEX, NEM, RCL, RTX, WEN, V, GNRC, CLF, HOOD, SOFI
Oct 29, 2026
•
WEN, CMCSA, V, NEM, RTX, CNC, GNRC, SOFI, RCL, CLF, IEX, HOOD, BIIB
